Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
NCT06161285 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-02-26
Summary
Acute bronchiolitis is a common disease in children under the age of two, caused mainly by the respiratory syncytial virus (RSV). Furthermore, given the same medical history, it is still very difficult to predict the course and severity of the infection at the onset of symptoms, Some studies have highlighted the importance of the microbiota (intestinal, oral or nasopharyngeal) and of the immune response to RSV in children, We will include 80 children under 2 years old with hospitalized bronchiolitis and non-hospitalized bronchiolitis. Oral, nasal and stool samples will be taken to study the various microbiota in search of dysbiosis. A capillary blood sample will be taken for immune studies.
Conditions
- Bronchiolitis
Interventions
- OTHER
-
Sampling
Single-time sampling of respiratory virus-infected children
Sponsors & Collaborators
-
Infectious Diseases Models for Innovative Therapies center
collaborator UNKNOWN -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Etienne BIZOT, Doctor · AP-HP Hôpital Antoine Beclere
Eligibility
- Min Age
- 1 Day
- Max Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-06
- Primary Completion
- 2026-03-31
- Completion
- 2026-04-30
Countries
- France
Study Locations
More Related Trials
-
Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.
NCT04077697 ·Status: COMPLETED
-
Birth Cohort Study for Respiratory Infections
NCT02361164 ·Status: COMPLETED
-
Innate Immune Response During Community Acquired Pneumonia
NCT03379207 ·Status: TERMINATED
-
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
NCT06286007 ·Status: RECRUITING
-
Development of an Atlas of Respiratory Host-microbiome Interactions in Healthy Volunteers
NCT06518161 ·Status: COMPLETED ·Phase: NA
-
Community-Acquired Pneumonia : Evaluation of Corticosteroids
NCT02517489 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Mycobacterium Xenopi Pulmonary Infection
NCT01298336 ·Status: COMPLETED ·Phase: PHASE3
-
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
NCT06349707 ·Status: COMPLETED
-
Non Invasive Diagnosis of Pneumocystis Pneumonia
NCT03613025 ·Status: COMPLETED ·Phase: NA
-
Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAP
NCT02668237 ·Status: COMPLETED ·Phase: NA
-
Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19)
NCT04365166 ·Status: UNKNOWN
-
Streptococcus Pneumoniae Nasopharyngeal Carriage
NCT01485029 ·Status: COMPLETED ·Phase: NA
-
Host-pathogen Interactions During SARS-CoV-2 Infection
NCT04376476 ·Status: COMPLETED ·Phase: NA
-
Predictors of Improvement and Deterioration of Community Acquired Pneumonia in Children
NCT06720441 ·Status: NOT_YET_RECRUITING
-
Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers
NCT02888457 ·Status: COMPLETED ·Phase: NA
-
Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy
NCT02912520 ·Status: COMPLETED
-
Immune Damage and Vaccination in COPD Patients
NCT03804138 ·Status: COMPLETED
-
Description of Pneumococcal Pneumonia
NCT03322670 ·Status: COMPLETED
-
Thermotherapy Against Persistent Bacterial LUNG Infections
NCT05351242 ·Status: RECRUITING ·Phase: NA
-
Seroepidemiological Study of Pertussis and Other Infectious Diseases
NCT01929473 ·Status: COMPLETED
-
Airway Microbiome of Patients With Protracted Bacterial Bronchitis
NCT07255430 ·Status: RECRUITING
-
Pediatric and Ambulatory Research in Infectious Diseases
NCT04471493 ·Status: RECRUITING
-
Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.
NCT05060146 ·Status: COMPLETED ·Phase: NA
-
Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections
NCT05536219 ·Status: RECRUITING
-
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NCT05280132 ·Status: RECRUITING ·Phase: NA